Wednesday, July 26 1:45 - 2:45 p.m. Exhibit Hall Theater 3 Supported by SARSTEDT
The session will explore the implementation of small volume S-Monovette primary tubes to reduce blood volume collected in a pediatric population. Additionally, the integration of these tubes with total laboratory automation will be described.
Brett Bartles CEO/President, SARSTEDT, Inc
Mark Kellogg, PhD, DABCC, FAACC Associate Director of Chemistry, Boston Children’s Hospital
Be the first to get all the latest news.